July 8, 2015 News by Isaura Santos 1200 People With Relapsing MS Needed For RPC1063, Avonex Clinical Trials Clinical investigatorsĀ worldwide are beginning to recruitĀ 1,200 patientsĀ with relapsing multiple sclerosisĀ for a study assessingĀ the effectiveness of two different doses of RPC1063 (Receptos, Inc.), an experimental oral therapy, and AvonexĀ® (interferon beta-1a, Biogen Inc.) in order toĀ reduce relapse rate in patients. This study, called the Sunbeam Study, is being funded by…
July 7, 2015 News by Isaura Santos Report Shows MS Patients Miss Out On Access To Palliative Care Services A recentĀ report by Marie Curie fellows organization suggests that those suffering fromĀ neurological conditions such as multiple sclerosisĀ are missing out on care that couldĀ make a major difference inĀ the quality of their lives. When it comes to palliative care, the report contends thatĀ there is a limited understanding about the need…
June 24, 2015 News by Isaura Santos Association Of British Neurologists Releases New Guidelines For Multiple Sclerosis The Association of British Neurologists (ABN)Ā recently published newĀ guidelines forĀ how Disease Modifying Therapies (DMTs) for relapsing remitting multiple sclerosis should be monitored and prescribed in the United Kingdom, emphasizing theĀ “right treatment at the right time.” There are currently ten DMTs available on the National Health System (NHS) and elevenĀ in…
April 8, 2015 News by Isaura Santos Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study A recent study suggests that in the futureĀ multiple sclerosis patients could benefit from treatments intendedĀ to boost their brain function. The study was published inĀ Nature NeuroscienceĀ and receivedĀ funding fromĀ The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…
February 24, 2015 News by Isaura Santos Pathological Progression of Multiple Sclerosis Documented For The First Time An international group of researchers fromĀ the Center for Brain Research at the MedUni ViennaĀ have published a paper in theĀ Lancet NeurologyĀ journal titledĀ “Pathological mechanisms in progressive multiple sclerosis,”Ā documenting the pathological progress of MS since its early stages to what is known about…
December 11, 2014 News by Isaura Santos MS Society Heralds 2014 as a Year Of Great Progress in Multiple Sclerosis Research 2014 was a year of major progress in research for treating and curingĀ multiple sclerosis (MS), according to the National Multiple Sclerosis Society. This year theĀ National Multiple Sclerosis Society reports that the organizationĀ invested over $50 million into 380 new and ongoing researchĀ initiatives and projects for MS. The SocietyĀ remains highly…
December 8, 2014 News by Isaura Santos Disappointing Results for Fingolimod Phase III Trial In Primary Progressive MS Novartis International recentlyĀ provided an update on itsĀ fingolimod Phase III trial evaluating the use of the drug inĀ primary progressive multiple sclerosisĀ (PPMS), reporting that the study did not reveal any significant benefits of prescribing fingolimod over a placebo.Ā However, results regarding…
December 8, 2014 News by Isaura Santos Ipsen Biopharmaceuticals Announces FDA To Review sBLA For DysportĀ® As Treatment For Upper Limb Spasticity Ipsen Biopharmaceuticals, IncĀ announced that the United States Food and Drug Administration (FDA) has agreed to review theĀ supplemental Biologics License Application (sBLA) for DysportĀ®Ā (abobotulinumtoxinA)Ā to treat upper limbĀ spasticity, a condition that affects many people in the United States, including multiple sclerosis (MS)…
November 19, 2014 News by Isaura Santos ‘Treat Me Right’ MS Society Campaign Shortlisted For Award TheĀ Treat Me RightĀ campaign from the MSĀ SocietyĀ in the UK was recentlyĀ shortlistedĀ for this year’s voluntary sector campaignĀ Public Affairs Award. The campaign was launched in April 2014 during MS Week to raise awareness for the importance of providing the right treatment at the right moment…
November 14, 2014 News by Isaura Santos Will It Be Possible To Predict Good And Bad Days For Multiple Sclerosis Patients? Highmark Blue Cross Blue Shield is trying to assess the possibility of predicting good and bad days for people suffering with multiple sclerosis (MS) and help them to achieve a higher quality of life. The four-week pilot program enrolled almost 100 participants that wore a body sensor patch,…
October 30, 2014 News by Isaura Santos Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software tool that helps researchers understand the complex genetic origins of many autoimmune diseases and, ultimately, to better diagnose and treat them. The study was published yesterday inĀ …
October 17, 2014 News by Isaura Santos “MS Radio” Offers Multiple Sclerosis Patients Breaking News, Articles & Tips About the Disease Multiple Sclerosis information resourceĀ MSology.com has announced the launch ofĀ MS Radio, an exclusive MS-focused radio program, to celebrate the organization’s second anniversary. MSology.com provides news, feature articles and practical tips to more than 100,000 people worldwide. The first radio episode (available here) is a…
October 14, 2014 News by Isaura Santos Multiple Sclerosis Patients Gain Access To Novel Image Sharing Platform StatRad is a technology leader in radiology and HealthCare Journey a virtual multiple sclerosis center and educator website guided by the motto,Ā Stop Searching Start Learning. According to a recentĀ press release, the two companies have teamed up to offer…